NRX-325008

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNRX-325008
Drug Alias NameNRX-325008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 agonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurocentrx Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNeurocentrx Pharma
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A